tirzepatide for iih idiopathic intracranial hypertension Idiopathic intracranial hypertension (IIH) A Phase Iv Placebo-Controlled Single
Description
Increased heart rate An increased heart rate is a less common side effect of Mounjaro
Mounjaro (Tirzepatide) Injection is a medicine that is used for weight loss and weight maintenance in adults
Maintaining compliance over months The biggest long-term risk of split dosing is adherence fatigue
Hair loss: Reported by some users of both medications, this is generally associated with rapid weight loss rather than the drugs themselves
When you inject your full weekly dose at once, tirzepatide concentration spikes to its highest point within 8 to 72 hours
